Ruxolitinib withdrawal complicating emergency aortic root replacement

Ruxolitinib, a Janus kinase inhibitor, is associated with severe withdrawal phenomena. Adequate tapering is often underemphasized in surgical emergencies and can complicate the postoperative course. We present a case of acute ruxolitinib withdrawal in a gentleman undergoing emergency cardiac surgery

Detalles Bibliográficos
Autores principales: Szpytma, Malgorzata (Maggie), Gimpel, Damian, Crouch, Gareth, Bennetts, Jayme S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Vascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201970/
https://www.ncbi.nlm.nih.gov/pubmed/35640536
http://dx.doi.org/10.1093/icvts/ivac143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201970/
https://www.ncbi.nlm.nih.gov/pubmed/35640536
http://dx.doi.org/10.1093/icvts/ivac143

Ejemplares similares